Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_assertion description "[Selective inhibition of PI3K? (p110?) by GS-1101 has emerged as a promising therapy in chronic lymphocytic leukemia and indolent lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_assertion evidence source_evidence_literature NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_assertion SIO_000772 23676220 NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_assertion wasDerivedFrom befree-20140225 NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_assertion wasGeneratedBy ECO_0000203 NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.
- befree-20140225 importedOn "2014-02-25" NP468227.RAkBfDan-dIxepbbGS6lk3XCkYxensYyPc6QxBT4NjB0E130_provenance.